Show simple item record

dc.contributor.authorLópez-Muñoz, F.
dc.contributor.authorGarcía-García
dc.contributor.authorÁlamo González, C
dc.date.accessioned2018-06-26T17:40:21Z
dc.date.available2018-06-26T17:40:21Z
dc.date.issued2014-09-24
dc.identifier.citationAlamo C, López-Muñoz F and García-García P. It is Possible Find an Antidepressant with Faster Onset of Action? Ketamine: Promise or Reality?. Ann Depress Anxiety. 2014;1(5): 1021.es
dc.identifier.issn2381-8883
dc.identifier.urihttp://hdl.handle.net/20.500.12020/768
dc.description.abstractMonoaminergic antidepressants have a delay in the onset of response that needs alternatives. Sub anesthetic doses of ketamine, a NMDA receptor antagonist, show a rapid-acting antidepressant effect in Major Depressive Disorder (MDD) and in bipolar depression, and improve suicidal ideation. However, for ketamine routinely use as antidepressant, more clinical research on the relation risks and benefits is needed to decide if ketamine is a promise or a realityes
dc.language.isoenes
dc.publisherAustin Publishing Groupes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleIt is Possible Find an Antidepressant with Faster Onset of Action? Ketamine: Promise or Reality?es
dc.typearticlees
dc.issue.number5es
dc.journal.titleAnnals of Depression and Anxietyes
dc.page.initial2es
dc.page.final4es
dc.rights.accessRightsopenAccesses
dc.subject.areaPsicologíaes
dc.subject.keywordDepressiones
dc.subject.keywordKetaminees
dc.subject.keywordFast responsees
dc.subject.keywordAntidepressant effectes
dc.subject.unesco3201.05 Psicología Clínicaes
dc.volume.number1es


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional